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Neutralization specificities of outer capsid spike protein VP4 of murine rotavirus strains EW (P?[16],G3) and EHP
(P?[20],G3) and lapine rotavirus strains Ala (P?[14],G3), C11 (P?[14],G3), and R2 (P?[14],G3) as well as human rotavirus
strains PA169 (P?[14],G6) and HAL1166 (P?[14],G8) were determined by two-way cross-neutralization. This was done by
generating and characterizing (i) three murine  human, three lapine  human, and two human  human single gene
substitution reassortant rotaviruses, each of which bore identical human rotavirus DS-1 strain VP7 (G2), and (ii) guinea pig
hyperimmune antiserum raised against each reassortant. Reference rotavirus strains employed in the study represented 10
established VP4 (P) serotypes, including 1A[8], 1B[4], 2A[6], 3[9], 4[10], 5A[2], 5B[2], 5B[3], 6[1], 7[5], 8[11], 9[7], and 10[16]
as well as a P serotype unknown P[18]. Murine rotavirus strains EW and EB were demonstrated to share the same P serotype
(P10[16]) distinct from (i) 9 established P serotypes, (ii) lapine and human rotavirus strains bearing the P[14] genotype, and
(iii) an equine rotavirus strain bearing the P[18] genotype. Both lapine (Ala, C11, and R2) and human (PA169 and HAL1166)
rotaviruses were shown to belong to the same VP4 serotype, which represented a distinct new P serotype (P11[14]). PINTRODUCTION
The group A rotaviruses are the single most important
etiologic agents of acute severe diarrhea in infants and
young children as well as in the young of many animal
species worldwide (Bern and Glass, 1994; Kapikian et al.,
2001). Rotavirus diarrhea is estimated to be responsible
for approximately 600,000–800,000 deaths each year in
children aged less than 5 years in developing countries
and more than 500,000 physician visits and 50,000 hos-
pitalizations annually in this same age group in the
United States alone (Kapikian et al., 2001; Glass et al.,
1994). Thus, the development of a safe and effective
vaccine has been a global public health goal and vigor-
ously pursued by various groups around the world
(Kapikian et al., 2001; Bresee et al., 1999).
A complete rotavirus particle carries two outer capsid
proteins, VP4 and VP7, which have been demonstrated to
induce protective neutralizing antibodies independently
(Greenberg et al., 1983; Hoshino et al., 1985, 1988; Offit
and Blavat, 1986; Offit et al., 1986a,b; Matsui et al., 1989;
Andrew et al., 1992; Both et al., 1993; Coste et al., 2000;
Gil et al., 2000). Thus, a dual system of rotavirus classi-
fication to designate the neutralization specificity of both
VP7 (G serotype) and VP4 (P serotype) outer capsid
1 To whom reprint requests should be addressed at ES/LID/NIAID/NIH,proteins has been established based on a criterion of
20-fold antibody differences between the homologous
and heterologous reciprocal neutralizing antibody titers
(Estes, 1996; Hoshino and Kapikian, 1996). Establishing
the VP4 (P) or VP7 (G) serotype specificity of a rotavirus
requires type-specific high titered polyclonal hyperim-
mune antisera. In order to circumvent the lack of readily
available reagents for serotyping and to enable the clas-
sification of a large number of rotavirus field isolates, a G
or P genotyping assay was developed in which “geno-
type-specific” primers were employed in RT–PCR. The
numbers assigned for G serotypes (types determined by
neutralization assay) and G genotypes (types determined
by a nonserological assay) are identical, and thus a
single number is used (e.g., G1). However, the numbers
assigned for P serotypes and P genotypes are different;
therefore, a P serotype is designated with a P followed
by the assigned number, whereas the P genotype is
designated by a P followed by the assigned number in
brackets (e.g., P1A[8]). If the genotype but not the sero-
type is known, then the P is followed by the bracketed
number only. The current status of VP4 (P) serotype
classification has been summarized (Table 4).
It is still unclear whether neutralizing antibodies are of
major importance in protecting infants and young chil-
dren against rotavirus diarrhea. However, there is in-serotype 13[20] was assigned to murine rotavirus EHP
serotypes/genotypes examined in the present study.
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creasing evidence from rotavirus vaccine field trials in-
dicating that serotype-specific immunity is important (re-strain64
viewed by Hoshino and Kapikian, 2000). In addition,
various practical animal models, such as mice and rab-
bits, have been used to investigate mechanisms involved
in rotavirus disease, infection, and immunity (Coelho et
al., 1981; Thouless et al., 1988; Conner et al., 1988; Ijaz et
al., 1989; Ward et al., 1990; Conner and Ramig, 1996;
Rose et al., 1998).
A murine rotavirus was the first group A rotavirus to be
described as a causative agent of diarrhea in mouse
pups and has been used extensively in a mouse model
to study rotavirus infection and immunity. Serotypic char-
acterization of the VP7 protein and complete nucleotide
and deduced amino acid sequences of the VP4 gene of
selected murine and lapine rotavirus strains have been
determined (Sato et al., 1982b; Thouless et al., 1986;
Greenberg et al., 1986; Tanaka et al., 1988; Nishikawa et
al., 1989; Dunn et al., 1994; Ciarlet et al., 1997). However,
characterization of the VP4 neutralization specificities of
such strains has never been performed except for the
murine rotavirus EB, which was shown by one-way neu-
tralization to be distinct from 5 of 9 known P serotypes
(1A[8], 1B[4], 2A[6], 2B[6], 3[9], 4[10], and 9[7]) and thus
assigned to P serotype 10[16] (Sereno and Gorziglia,
1994). Of interest is the finding that lapine rotavirus
strains and certain human rotavirus strains share the
same VP4 genotype specificity (P[14]) (Ciarlet et al.,
1997). The purpose of this study was to characterize the
neutralization specificity of the VP4 protein of selected
murine, lapine, and human rotavirus strains by two-way
cross-neutralization based on a criterion of a 20-fold
antibody difference.
RESULTS AND DISCUSSION
Generation and characterization of murine  human
G2 rotavirus reassortants
We generated (i) three single gene substitution mu-
rine  human rotavirus reassortants, each of which had
10 genes from human rotavirus DS-1 strain (P1B[4],G2)
and only the VP4 gene from murine rotavirus strains EB,
EW, or EHP (Fig. 1) and (ii) hyperimmune guinea pig
antiserum to each of the three murine human rotavirus
reassortants. Each reassortant was confirmed by VP7-
specific monoclonal antibody (mAb)-based serotyping
enzyme-linked immunosorbent assay (ELISA) to carry G2
specificity (data not shown).
When hyperimmune antiserum raised to EB  DS-
1(P10[16],G2) or EW  DS-1 (P[16],G2) was tested in
plaque reduction neutralization (PRN) assays against
various rotavirus strains representing a battery of P se-
rotypes and genotypes, each serum neutralized only the
VP7-homotypic DS-1 strain, the VP4-homotypic EB
(P10[16],G3) and EW (P[16],G3) strains, as well as the
homotypic reassortants, suggesting that strains EB and
EW belonged to the same P serotype (Table 1). Since the
VP4-specific neutralizing antibody titers were consider-
ably lower than those to the G2 parent and the reassor-
tant, we evaluated a high titered hyperimmune antiserum
to the EB strain by neutralization against selected rota-
virus strains representing the 10 established P serotypes
and 2 genotypes. This confirmed that the VP4 neutraliza-
tion specificities of the EB and EW strains were essen-
tially similar, if not identical.
The VP7-homotypic DS-1 strain and the VP4-homo-
typic EHP strain (P[20]) were the only viruses to be
neutralized significantly by anti-EHP  DS-1 (P[20],G2)
guinea pig hyperimmune antiserum, indicating that mu-
rine rotavirus EHP strain represented a P serotype dis-
tinct from the battery of P serotypes established thus far
(Table 1).
When the reassortants EB  DS-1 and EW  DS-1
were examined by PRN against guinea pig hyperimmune
antisera raised to rotavirus strains belonging to a battery
of P serotypes as well as three strains of unknown
serotype (P[14], P[18], or P[20]), they were neutralized
only by VP7-homotypic anti-DS-1 antiserum and VP4-
homotypic anti-EB antiserum (Table 2), which indicated
again that strains EB and EW shared the same VP4
serotype specificity, which was distinct from all the P
serotypes and strains of unknown serotype tested in this
study. Similarly, VP7-homotypic antiserum to DS-1 and
VP4-homotypic antiserum to EHP were the only hyper-
immune antisera that neutralized EHP  DS-1 reassor-
tant, confirming that strain EHP carried a P serotype
FIG. 1. Electrophoretic migration patterns of genomic RNAs of murine
rotavirus EB strain (lane 1), reassortant EB  DS-1 (lane 2), human
rotavirus DS-1 strain (lane 3), reassortant EW  DS-1 (lane 4), murine
rotavirus EW strain (lane 5), murine rotavirus EHP strain (lane 6),
reassortant EHP DS-1 (lane 7), and human rotavirus DS-1 strain (lane
8) in a 10% polyacrylamide gel. Genomic RNAs were electrophoresed
at 8 mA for 15 h and the resulting migration patterns were visualized by
staining of the gel with silver nitrate.
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distinct from 10 P serotypes established thus far and 2 P
genotypes (P[14] and P[18]) tested in this study.
Generation and characterization of single gene
substitution lapine  human G2 and human P[14] 
human G2 rotavirus reassortants
We generated three lapine  human G2 and two
human P[14]  human G2 single gene substitution rota-
virus reassortants, each of which had either (i) 10 genes
from the human DS-1 strain and only the VP4 gene from
lapine rotavirus (Ala  DS-1) or (ii) only the VP7 gene
from the DS-1 strain and the remaining 10 genes from a
lapine (C11  DS-1 or R2  DS-1) or human P[14] strain
(PA169  DS-1 or HAL1166  DS-1) (Figs. 2 and 3). Each
of the five reassortants was confirmed by serotyping
ELISA to carry G2 specificity (data not shown). Guinea
pig hyperimmune antiserum to each reassortant was
also generated.
Guinea pig hyperimmune antiserum to Ala  DS-1
(P[14],G2) or C11  DS-1 (P[14],G2) neutralized homolo-
gous lapine Ala (P[14],G3) and C11 (P[14],G3) strains or
VP4 genotypically identical human PA169 (P[14],G6) or
HAL1166 (P[14],G8) strains to a high titer and the VP4
genotypically identical lapine R2 strain (P[14],G3) to a
fourfold lower titer (Table 3), indicating that the three
lapine and two human rotavirus strains shared the same
VP4 neutralization specificities. The same antisera
showed only a low-level cross-reactivity to certain rota-
virus strains, indicating that such strains were not sig-
nificantly related.
Anti-R2  DS-1 (P[14],G2) antiserum neutralized the
homologous lapine R2 strain and heterologous human
PA169 and HAL1166 strains to a high titer and the lapine
Ala and C11 strains 16-fold lower than the homologous
R2 strain (Table 3), which indicated that the Japanese
lapine rotavirus (R2) VP4 was more closely related sero-
typically to human P[14] VP4s than to the United States
lapine rotavirus (Ala and C11) VP4s.
TABLE 1
Characterization by Neutralization of VP4 of Selected Murine Rotavirus Strains
Rotavirus
strain
Species of
origin
P type
[genotype] G type
Reciprocal of 60% PRN antibody titer of guinea pig hyperimmune
antiserum to indicated rotavirus
EW  DS-1
(P[16],G2)
EB  DS-1
(P10[16],G2)
EB
(P10[16],G3)
EHP  DS-1
(P[20],G2)
Wa Human 1A[8] 1 80 80 80 80
DS-1 Human 1B[4] 2 10,240*** 10,240 80 10,240
DS-1  UK RT* 1B[4] 6 80 80 NT 80
ST3 Human 2A[6] 4 80 80 80 80
K8 Human 3[9] 1 80 80 80 80
69M Human 4[10] 8 80 80 80 80
Ro1845 Human 5A[3] 3 80 80 NT 80
Ro1845  DS-1 RT 5A[3] 2 NT** NT 80 NT
SA11 Vervet monkey 5B[2] 3 80 80 NT 80
SA11  DS-1 RT 5B[2] 2 NT NT 80 NT
MMU18006 Rhesus monkey 5B[3] 3 80 80 NT 80
MMU18006  DS-1 RT 5B[3] 2 NT NT 80 NT
NCDV Bovine 6[1] 6 80 80 80 80
UK Bovine 7[5] 6 80 80 80 80
B223 Bovine 8[11] 10 80 80 80 80
OSU Porcine 9[7] 5 80 80 80 80
EW Murine [16] 3 640**** 320 5,120 80
EB Murine 10[16] 3 320 320 10,240 80
PA169 Human [14] 6 80 80 80 80
Ala Lapine [14] 3 80 80 NT 80
L338 Equine [18] 13 80 80 80 80
EHP Murine [20] 3 80 80 NT 2,560
EW  DS-1 RT [16] 2 20,480***** NT 1,280 NT
EB  DS-1 RT 10[16] 2 NT 40,960 2,560 NT
EHP  DS-1 RT [20] 2 NT NT 80 40,960
* RT, reassortant.
** NT, not tested.
*** VP7 homologous values in bold.
**** VP4 homologous values underlined.
***** VP7 and VP4 homologous values in bold and underlined.
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Guinea pig antiserum to PA169  DS-1 or HAL1166 
DS-1 neutralized homologous human PA169 and HAL1166
viruses to a high titer and heterologous lapine R2 virus
8-fold lower than the homologous viruses, confirming a
close VP4 serotypic relationship between human P[14] vi-
ruses and lapine R2 virus (Table 3). These antisera neutral-
ized lapine Ala and C11 viruses 64- to 128-fold less effi-
ciently than they did against the homologous viruses, which
indicated again that the human P[14] virus VP4s were more
closely related serotypically to the Japanese lapine rotavi-
rus R2 VP4 than those of the United States lapine rotavi-
ruses (Ala and C11). It is of interest that consistent with
these results, previous comparative VP4 amino acid se-
quence analysis suggested a closer relatedness of the
Japanese lapine R2 virus to the human P[14] viruses (PA169
and HAL1166) than to the United States lapine Ala and C11
viruses (Ciarlet et al., 1997).
Reassortants Ala  DS-1, C11  DS-1, R2  DS-1,
PA169  DS-1, and HAL1166  DS-1 were neutralized by
antiserum to the VP7-homotypic DS-1 and antiserum to
VP4-homotypic Ala, C11, R2, or PA169 strains (Table 2),
which confirmed a close VP4 serotypic relationship
among these five P[14] viruses. Thus, this study has
shown that (i) lapine rotavirus strains Ala, C11, and R2
and human rotavirus strains PA169 and HAL1166 belong
to the same P serotype and (ii) human rotavirus PA169
and HAL1166 VP4s are more closely related serotypical-
lyto the Japanese lapine rotavirus R2 VP4 than those of
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FIG. 2. Electrophoretic migration patterns of genomic RNAs of lapine
rotavirus Ala strain (lane 1), reassortant Ala  DS-1 (lane 2), human
rotavirus DS-1 strain (lane 3), reassortant C11  DS-1 (lane 4), lapine
rotavirus C11 strain (lane 5), lapine rotavirus R2 strain (lane 6), reas-
sortant R2  DS-1 (lane 7), and human rotavirus DS-1 strain (lane 8) in
a 10% polyacrylamide gel. Genomic RNAs were electrophoresed at 8
mA for 15 h and the resulting migration patterns were visualized by
staining of the gel with silver nitrate.
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the United States lapine rotavirus Ala and C11 strains. It
is of interest that human rotavirus strains bearing the
P[14] genotype, which were first reported from Italy 11
years ago (Gerna et al., 1992), have been detected re-
cently, albeit sporadically, in various parts of the world,
including Thailand (Urasawa et al., 1992), Italy (Gerna et
al., 1992), Finland (Gerna et al., 1994), South Africa
(Mphahlele et al., 1999), Australia (Palombo et al., 1995),
and Egypt (Holmes et al., 1999).
As described in this study, mAbs directed to the VP4
protein often show cross-reactivity. Therefore, we have
chosen to generate polyclonal hyperimmune antiserum
to a reassortant with the VP4 specificity of the strain
being studied because such sera have been shown to be
VP4 serotype-specific (Hoshino and Kapikian, 1996). Pre-
viously, P serotypes of human rotavirus strains K8
(P3[9],G1) and Mc35 (P[14],G10) were tentatively desig-
nated P3A[9] and P3B[14], respectively (Urasawa et al.,
1993). This classification was based on (i) the relatively
high sequence homology of the VP4 gene of K8 and
Mc35 (77.6% nucleotide and 86.0% amino acid se-
quence homologies, respectively) and (ii) the signifi-
cant recognition by neutralization of the Mc35 strain
with a single mAb raised against the K8 VP4. However,
it was shown later that polyclonal hyperimmune
guinea pig antiserum raised against the VP4 of PA169
(P[14],G6) failed to neutralize significantly a P3[9] virus
designated the AU-1 strain (which as noted above for
the K8, a P3[9] strain, had been considered to be
related to the Mc35, a P[14] strain), and thus, the VP4
serotype of PA169 was proposed to represent a new P
serotype (Gerna et al., 1994). Of note is the finding that
in the latter study, three of four mAbs raised against
the PA169 VP4 (P[14]) were shown to demonstrate
significant cross-reactivities in neutralization to vari-
ous P types, including P1A[8], P2A[6], and P5B[3].
However, the observation made in that study that there
was no significant VP4 serotypic relatedness between
AU-1 (a P3[9] strain) and PA169 (a P[14] strain) by neutral-
ization with hyperimmune sera was confirmed in the
present study. Hence, we propose that the VP4 serotype of
these strains bearing the P[14] genotype be assigned to a
new P serotype (P11). Consequently, the VP4 serotype of
human rotavirus strains Mc323 (P[19],G9) and Mc345
(P[19],G9), which was assigned to P serotype 11 initially
(Okada et al., 2000), would be reassigned to P serotype 12.
Hence, the VP4 serotype of the murine rotavirus EHP strain
(P[20],G3), which has been shown in this study to be dis-
tinct, would be assigned to P serotype 13.
MATERIALS AND METHODS
Rotavirus strains, cell cultures, virus titration,
neutralization assay, and hyperimmune antiserum
Tables 1 and 3 summarize the rotavirus strains as well
as their G and P type specificities employed in the
present study. Origins of murine rotavirus strains EW
(P[16],G3) (isolated in the United States), EB (P10[16],G3)
(isolated in the United States), and EHP (P[20],G3) (iso-
lated in Brazil) have been described in detail previously
(Greenberg et al., 1986). Lapine rotavirus strains Ala
(P[14],G3) and C11 (P[14],G3) were isolated in the United
States (Thouless et al., 1986) and the R2 strain (P[14],G3)
in Japan (Sato et al., 1982a). Human rotavirus strains
PA169 (P[14],G6) and HAL1166 (P[14],G8) were isolated in
Italy (Gerna et al., 1992) and in Finland (Gerna et al.,
1994), respectively. Each rotavirus strain was triply
plaque-purified before use. The established monkey kid-
ney cell line MA104 was used for virus propagation,
plaque purification, plaque titration, and PRN assay.
Plaque titration and the PRN assay were performed in a
six-well plate as described previously (Hoshino et
al.,1998). Hyperimmune antiserum to each reference ro-
tavirus strain as well as to each reassortant was raised
as described previously (Wyatt et al., 1982) in specific
pathogen-free guinea pigs (National Cancer Institute,
Frederick, MD) which were free of neutralizing antibod-
FIG. 3. Electrophoretic migration patterns of genomic RNAs of hu-
man rotavirus PA169 (lane 1), reassortant PA169  DS-1 (lane 2),
human rotavirus DS-1 strain (lane 3), reassortant HAL1166  DS-1
(lane 4), and human rotavirus HAL1166 strain (lane 5) in a 10% poly-
acrylamide gel. Genomic RNAs were electrophoresed at 8 mA for 15 h
and the resulting migration patterns were visualized by staining of the
gel with silver nitrate.
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ies to all the rotavirus strains employed in the study (e.g.,
PRN antibody titer 1:20 vs Wa).
Generation and characterization of reassortant
rotaviruses
Each reassortant rotavirus was generated as previ-
ously described (Hoshino et al., 1998). Because cer-
tain combinations of outer capsid proteins VP4–VP7
have been reported to affect the rotavirus antigen–
antibody interaction (Chen et al., 1989), we utilized the
identical VP7 protein (G2) in each reassortant. Briefly,
tube cultures of MA104 cells were coinfected with two
parental rotavirus strains at a m.o.i. approximately 1.
When approximately 75% of the infected cells showed
cytopathic effects, the cultures were frozen and
thawed once and plated on MA104 cells in a six-well
plate in the presence of (i) serotype-G3-specific mAb
159 (Greenberg et al., 1983) to generate reassortant
EB  DS-1, EW  DS-1, EHP  DS-1, Ala  DS-1,
C11  DS-1, or R2  DS-1, (ii) serotype-G6-specific
mAb UK/7 (Snodgrass et al., 1990) to generate
PA169  DS-1, or (iii) hyperimmune antiserum raised
against strain 69M (P4[10],G8) to generate HAL1166 
DS-1. Desired reassortants selected in this manner
were triply plaque-purified in MA104 cells. The plaque-
purified reassortants were examined for G serotype by
ELISA using type-specific VP7 neutralizing mAbs
(Green et al., 1990). The origin of the genes of each
reassortant was determined by polyacrylamide gel
electrophoresis (PAGE) of its genomic RNAs. The ori-
gin of the genes undetermined by PAGE was con-
firmed by constant denaturant gel electrophoresis
(Jones et al., in press).
ACKNOWLEDGMENTS
We thank Jerri Ross and Monica Bur for expert technical assistance,
Dr. David Snodgrass (BioBest, Edinburgh, Scotland) for providing mAb
UK/7, and Dora Kyle for editorial assistance in the preparation of the
manuscript.
TABLE 3
Characterization by Neutralization of VP4 of Selected P[14] Lapine and Human Rotavirus Strains
Rotavirus
strain
Species
of origin
P type
[genotype]
G
type
Reciprocal of 60% PRN antibody titer of guinea pig
hyperimmune antiserum to indicated reassortant
Ala  DS-1
(P[14],G2)
C11  DS-1
(P[14],G2)
R2  DS-1
(P[14],G2)
PA169  DS-1
(P[14],G2)
HAL1166  DS-1
(P[14],G2)
Wa Human 1A[8] 1 80 80 80 80 80
DS-1 Human 1B[4] 2 40,960** 81,920 5,120 81,920 10,240
DS-1  UK Reassortant 1B[4] 6 80 80 80 80 80
ST3 Human 2A[6] 4 80 80 80 80 80
K8 Human 3[9] 1 80 160 80 160 160
69M Human 4[10] 8 80 80 80 80 160
Ro1845 Human 5A[3] 3 80 160 80 160 80
SA11 Vervet monkey 5B[2] 3 160 80 80 80 80
MMU18006 Rhesus monkey 5B[3] 3 320 320 80 160 160
NCDV Bovine 6[1] 6 80 80 80 80 160
UK Bovine 7[5] 6 80 80 80 80 80
B223 Bovine 8[11] 10 80 80 80 80 80
OSU Porcine 9[7] 5 80 80 80 80 160
EB Murine 10[16] 3 80 80 80 80 80
Ala Lapine [14] 3 10,240*** 10,240 160 160 320
C11 Lapine [14] 3 10,240 10,240 160 160 160
R2 Lapine [14] 3 2,560 2,560 2,560 1,280 2,560
PA169 Human [14] 6 10,240 10,240 5,120 10,240 5,120
HAL1166 Human [14] 8 10,240 10,240 2,560 10,240 20,480
EHP Murine [20] 3 80 80 80 80 80
Ala  DS-1 Reassortant [14] 2 40,960**** NT NT NT NT
C11  DS-1 Reassortant [14] 2 NT* 40,960 NT NT NT
R2  DS-1 Reassortant [14] 2 NT NT 10,240 NT NT
PA169  DS-1 Reassortant [14] 2 NT NT NT 10,240 NT
HAL1166  DS-1 Reassortant [14] 2 NT NT NT NT 40,960
* NT, not tested.
** VP7 homologous values in bold.
*** VP4 homologous values underlined.
**** VP7 and VP4 homologous values in bold and underlined.
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